SeeMe: An Automated Tool to Detect Early Recovery After Brain Injury

Launched by STONY BROOK UNIVERSITY · Oct 10, 2023

Keywords

ClinConnect Summary

The SeeMe clinical trial is studying a new tool designed to help doctors better understand how patients are recovering from brain injuries, especially those who are in a coma. The tool, called "SeeMe," measures facial movements to see how well a patient responds to spoken commands, like "open your eyes." This could help doctors predict recovery outcomes more accurately than current methods, which mainly rely on physical exams and scoring systems.

To participate in this study, individuals must be at least 18 years old, and they can either be healthy volunteers or patients in a coma due to an acute brain injury, such as a traumatic brain injury. However, those with certain medical conditions that could complicate their care, pregnant individuals, or those who cannot provide legal consent cannot join. If eligible, participants will undergo assessments using the SeeMe tool, which may help improve future care for patients with similar injuries.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 years old or older
• • Healthy Volunteers
• • Comatose patients (patients with a GCS \< 9) due to an acute brain injury (traumatic brain injury, spontaneous subarachnoid hemorrhage, severe meningoencephalitis, etc.)
• Exclusion Criteria:
• • A history of a neurologically debilitating disease (i.e., dementia, glioblastoma, Alzheimer's, multiple sclerosis, major vessel stroke, previous severe TBI, etc.)
• • Any other medical condition that, in the judgment of the investigator, makes participation in the study unsafe.
• • Pregnant subjects
• • Comatose patients without a legal authorized representative (LAR)
• • Prisoners or wards of the state
• • Persons who have not attained the legal age for consent to treatments or procedures